CARCINOMA OF LARYNX

Clinical trials for CARCINOMA OF LARYNX explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA OF LARYNX trials appear

Sign up with your email to follow new studies for CARCINOMA OF LARYNX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New pill-chemo combo takes on hard-to-treat cancers

Disease control Not yet recruiting

This study tests a new drug called SX-682 (a tablet) combined with the chemotherapy docetaxel in people whose head/neck, salivary gland, or prostate cancer has spread or returned after treatment. The goal is to find the right dose and see if the combination shrinks tumors. About …

Matched conditions: CARCINOMA OF LARYNX

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 02, 2026 07:00 UTC

CARCINOMA OF LARYNX

Get alerted when new CARCINOMA OF LARYNX trials appear

New pill-chemo combo takes on hard-to-treat cancers